Some shampoos in the market include estrogens and the extracts of placenta, whereas others contain Phytoestrogens. There are reports of cases of small children to develop to breasts after the exhibition to these shampoos. The 9 of September of 1993, the FDA determined that all those of topical application that contain hormones products of free drug sale for human consumption generally are not recognized as safe and effective and badly are labeled. A norm proposal takes care of support with the cosmetics, concluding that the natural estrogen use in a cosmetic product does that the product non approved a new drug and that any cosmetic to use the term “hormone” in the text of the label or its declaration of ingredients makes an implicit claim of drugs, putting under this type of product to the regulating action.
In addition to being considered labeled medicines bad, the products that they try to also contain the placenta extract can be considers labeled badly of cosmetics if the extract has been prepared from the placentas of which the biologically active hormones and other substances have been eliminated and the extracted substance consists mainly of proteins. The FDA recommends that this substance is identified by a name that is not “the placenta to extract” and more accurately to describe their composition, because the consumers associate the name of “placenta extract”, with a therapeutic use of some biological activity.